Big Pharma is Fueling Republicans’ Radical MAGA Agenda for 2025
Big Pharma has invested big money in the organizations planning what a MAGA policy agenda will look like in a new Trump administration. Not surprisingly, that policy playbook contains a major gift for the drug industry: a swift end to the Biden administration’s landmark program to allow Medicare to negotiate lower drug prices.
For two decades, Congress barred Medicare from negotiating prescription drug prices, which is a major reason why Americans pay higher prices for drugs than anyone else in the world. In 2022,…